Author

Rodney Scott

Observed name: Scott, Rodney

Institutions: John Hunter Hospital, Hunter Medical Research Institute, Hunter New England Local Health District, University of Newcastle Australia

Observed institutions: University of Cambridge, John Hunter Hospital, Population Health Research Institute, Hunter Medical Research Institute, Hunter New England Local Health District, Addenbrooke's Hospital, MRC Epidemiology Unit, University of Newcastle Australia

OpenAlex ID: A5129636637

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

2019 · Amand F Schmidt, Michael V Holmes, et al. · BMC Cardiovascular Disorders · 43

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres

2024 · Amanda Spurdle, Cristina Fortuno, et al. · European Journal of Human Genetics · 2

The role of heparanase in organ allograft rejection and the effect of heparanase inhibition on allograft survival

2026 · Adrian Hibberd, David Clark, et al. · Transplant Immunology

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies

2026 · Daniel Adams, Amber N Hurson, et al. · JNCI Journal of the National Cancer Institute

Are current Polish guidelines for prophylactic mastectomy sufficient?

2026 · Adam Stachowski, Cezary Cybulski, et al. · Hereditary Cancer in Clinical Practice

Additional file 1: of Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

2015 · Thompson, Ella, Gorringe, Kylie, et al. · Figshare

Additional file 2: of Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls

2015 · Thompson, Ella, Gorringe, Kylie, et al. · Figshare

Works count: 12

Citation count: 45

H-index: 2

I10-index: 1